Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21668,785,1.00 [0.96-1.05],0.8740520343147227
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21665,127,1.05 [0.92-1.20],0.4344525261827291
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23036,134,1.02 [0.92-1.14],0.6844010091393421
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17170,438,1.04 [0.97-1.11],0.2649643667263862
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22982,80,1.08 [0.94-1.25],0.2735136717630489
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22352,71,1.06 [0.92-1.23],0.4337677565660999
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23863,79,1.08 [0.94-1.25],0.2888999557476573
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23884,53,1.00 [0.82-1.24],0.9672049636606344
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21876,40,0.91 [0.70-1.18],0.4684954735642835
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23427,96,1.00 [0.86-1.16],0.9738775773990356
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23392,61,1.07 [0.90-1.26],0.44600183995783
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23921,57,1.13 [1.00-1.29],0.054381154086163
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23885,90,0.90 [0.77-1.06],0.1966726735925553
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23877,82,0.90 [0.76-1.06],0.2140765315079273
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Mycoses,23725,45,1.09 [0.93-1.27],0.2932153929857521
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23165,334,0.97 [0.90-1.05],0.4735203798020707
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22952,121,0.91 [0.78-1.06],0.2461816710483092
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23049,218,0.96 [0.86-1.07],0.4714533147730151
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",20731,28,0.90 [0.57-1.43],0.6489670821243839
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20746,43,0.94 [0.72-1.22],0.6392970982814612
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20816,113,1.07 [0.94-1.22],0.3229666931132364
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20821,118,1.06 [0.93-1.21],0.3634275854010681
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",11644,258,0.82 [0.74-0.92],0.0009600397617628
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9338,21,0.24 [0.10-0.55],0.0007972596179357
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20746,43,0.80 [0.58-1.10],0.1633755301689117
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22102,702,1.08 [1.03-1.13],0.0006241749783829
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23025,182,0.85 [0.71-1.02],0.0782137441183911
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23558,73,0.79 [0.57-1.09],0.14592276232885
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23989,69,0.86 [0.65-1.14],0.2940678523189931
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Rectum,23787,41,0.83 [0.56-1.25],0.3751392533310045
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23992,32,0.97 [0.71-1.34],0.8672173774990178
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Stomach,24027,25,1.00 [0.70-1.43],0.9880195659899654
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm,23761,260,0.92 [0.83-1.02],0.119442846221452
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23968,103,0.95 [0.81-1.10],0.4816807323684106
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23973,80,0.84 [0.66-1.07],0.1512338428177913
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23942,40,1.12 [0.95-1.34],0.1860191332649208
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Haemangioma, any site",23944,40,1.12 [0.95-1.34],0.1859844743428377
RLN2,Prorelaxin H2,Chapter II Neoplasms,Melanocytic naevi,23848,207,1.08 [1.01-1.16],0.0271741897099809
RLN2,Prorelaxin H2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23993,94,1.10 [0.99-1.21],0.0803588705780901
RLN2,Prorelaxin H2,Chapter II Neoplasms,Other benign neoplasms of skin,23907,161,1.07 [0.97-1.18],0.2028361472740956
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of breast,13253,81,1.02 [0.91-1.14],0.7273041783046006
RLN2,Prorelaxin H2,Chapter II Neoplasms,Leiomyoma of uterus,12950,607,0.94 [0.89-0.99],0.0247005212442741
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23162,169,1.11 [1.02-1.21],0.0145846052556749
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23064,302,1.10 [1.03-1.17],0.0059417810094787
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23064,302,1.10 [1.03-1.17],0.0059417810094787
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),21989,307,0.98 [0.90-1.07],0.6574024713845525
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23601,68,0.53 [0.35-0.80],0.002668129786305
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23810,88,0.89 [0.75-1.07],0.2108028771015753
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21059,610,1.01 [0.94-1.08],0.7938345974398303
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22923,376,1.09 [1.03-1.16],0.0062304874235637
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22446,92,0.98 [0.85-1.14],0.8322102394716135
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23352,51,1.03 [0.81-1.31],0.808589794726392
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22434,80,0.98 [0.84-1.15],0.7998172948343403
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22632,278,1.00 [0.91-1.11],0.952492113475848
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22625,271,1.01 [0.92-1.12],0.8094508557789462
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22331,157,1.04 [0.91-1.19],0.5520491161455059
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22335,155,1.03 [0.91-1.18],0.6169317322198467
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20922,473,0.95 [0.86-1.04],0.2341341766516764
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20512,63,0.91 [0.68-1.21],0.5188973751029253
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,20885,436,0.95 [0.86-1.04],0.2549707538505088
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20490,41,1.14 [0.96-1.35],0.126763993520473
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20511,62,0.95 [0.77-1.18],0.6541366285697835
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Any mental disorder,20810,657,0.95 [0.90-1.01],0.1326690648364079
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20405,252,0.88 [0.78-1.00],0.0419240311254193
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23649,189,0.85 [0.73-0.98],0.0304941354306695
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23704,137,0.82 [0.67-0.99],0.0409345464101715
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22302,67,0.92 [0.77-1.12],0.4146514935461333
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23930,67,0.92 [0.76-1.11],0.3961882059376241
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",20220,67,0.92 [0.76-1.11],0.3909653734066851
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Alcohol dependence,22314,79,0.79 [0.61-1.03],0.0845227190075387
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Smoking dependency,22277,61,0.86 [0.64-1.15],0.3036244020625429
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20221,68,0.91 [0.75-1.10],0.3289226848658066
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20481,328,1.02 [0.95-1.10],0.5626430256825241
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Depression,22518,284,1.01 [0.93-1.09],0.8493142256408566
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Depression or dysthymia,20357,248,1.01 [0.93-1.10],0.8314436748738535
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20275,122,0.93 [0.81-1.07],0.3322461740086282
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Other anxiety disorders,22728,55,1.00 [0.82-1.23],0.9897029532614572
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Neurological diseases,21378,1270,0.99 [0.95-1.04],0.7568510719092385
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19911,151,0.91 [0.79-1.04],0.1698689159404572
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23838,123,0.90 [0.78-1.05],0.1848698894247851
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22877,425,0.94 [0.87-1.02],0.1423485577960315
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Epilepsy,22594,142,0.94 [0.83-1.07],0.346941571675975
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Migraine,22537,85,0.96 [0.82-1.13],0.6127168015575638
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23705,76,0.96 [0.81-1.13],0.607215261073626
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23606,37,0.99 [0.71-1.37],0.9476963508610088
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other sleep disorders,22604,152,0.95 [0.82-1.10],0.4825168283087155
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Sleep apnoea,23491,116,0.94 [0.79-1.11],0.4424235463535887
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23039,534,1.00 [0.94-1.07],0.8935381872266632
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22629,124,0.93 [0.80-1.06],0.2793516376591181
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22792,287,1.07 [0.99-1.16],0.0876611908079682
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23837,76,1.00 [0.85-1.17],0.9984216798352904
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Hemiplegia,23810,49,1.04 [0.87-1.26],0.6615683224403031
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other neurological diseases,23652,104,0.99 [0.86-1.13],0.8541385625797455
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23617,272,0.98 [0.90-1.07],0.6624103031934601
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23490,145,1.04 [0.93-1.17],0.5142735166870631
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23423,78,0.92 [0.78-1.09],0.3558337514284798
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23431,86,1.02 [0.88-1.19],0.7548434774004562
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23388,43,0.99 [0.79-1.24],0.9215375021676852
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22517,52,1.13 [0.89-1.43],0.3298921773792967
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22627,162,1.10 [0.98-1.24],0.1033444022711832
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23490,106,1.00 [0.86-1.17],0.9682457422124092
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23808,18,1.15 [0.90-1.47],0.2538350734919954
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1525,18,1.23 [0.95-1.60],0.1153934251067723
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",22301,18,1.15 [0.90-1.47],0.256484141732569
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23699,43,1.08 [0.84-1.38],0.5366212555626928
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23679,23,1.06 [0.73-1.52],0.7615023276414529
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23608,81,0.98 [0.82-1.16],0.809968059283214
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23666,88,0.97 [0.82-1.14],0.67947802528018
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23913,112,1.04 [0.92-1.18],0.54718038635135
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,23560,83,0.92 [0.77-1.10],0.3393467367639876
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18756,1711,0.97 [0.92-1.01],0.1583765109380916
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23757,36,1.07 [0.85-1.34],0.549244022323343
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19671,1152,1.00 [0.95-1.05],0.9685067165600316
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypertension,19688,1169,1.00 [0.95-1.06],0.9057305373893814
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18552,33,1.22 [1.04-1.44],0.0164739695723399
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22733,496,0.97 [0.89-1.06],0.4954931190631085
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Angina pectoris,22537,300,0.98 [0.88-1.09],0.6790678114807023
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23405,117,0.73 [0.56-0.96],0.0250239698432173
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23512,224,0.84 [0.72-0.99],0.04023009171201
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23930,50,0.88 [0.61-1.25],0.466509265530844
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22377,140,0.91 [0.76-1.10],0.3324830116785582
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22600,372,0.95 [0.86-1.06],0.3840981719262415
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23575,72,0.81 [0.61-1.07],0.1305559708143429
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23581,153,0.91 [0.78-1.06],0.2260853593473991
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23563,60,0.82 [0.61-1.11],0.1963822202843235
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23564,61,0.81 [0.60-1.10],0.1767273752841752
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18576,57,0.83 [0.62-1.12],0.2243882523583787
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21741,40,0.89 [0.63-1.25],0.5035434257053535
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Conduction disorders,21765,64,0.81 [0.61-1.09],0.1698225857888253
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16354,79,1.10 [0.97-1.26],0.1433902255919182
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16443,168,1.01 [0.89-1.14],0.8855994855560213
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other arrhythmias,21738,37,1.00 [0.79-1.28],0.990815584538824
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21753,52,0.91 [0.71-1.18],0.4835549871419472
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23580,108,1.07 [0.93-1.24],0.3609256500901119
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23558,95,1.08 [0.95-1.23],0.2382715638751544
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23588,70,1.03 [0.87-1.23],0.7027888275014664
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23630,61,1.04 [0.86-1.25],0.690683905665672
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23367,44,1.08 [0.88-1.33],0.4407332938051754
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23398,75,1.00 [0.83-1.21],0.9612576706263714
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22975,100,0.96 [0.81-1.13],0.6081802291978297
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22958,83,0.95 [0.79-1.14],0.5832035903097875
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23885,81,0.94 [0.78-1.14],0.512986273674661
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Varicose veins,23250,375,1.04 [0.98-1.11],0.1825058874839915
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypotension,23391,44,0.98 [0.78-1.22],0.8324848751922629
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20310,1694,0.99 [0.95-1.02],0.5387845673350865
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23827,118,0.99 [0.88-1.11],0.8666152096232673
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22979,163,1.05 [0.95-1.16],0.3541816868421552
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22954,138,1.07 [0.96-1.19],0.2445238270340879
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23479,192,0.95 [0.84-1.07],0.3721129449992926
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23478,191,0.95 [0.84-1.07],0.3924184146476335
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23251,574,0.96 [0.90-1.02],0.1434684185027109
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22766,89,0.81 [0.65-1.01],0.0662006749809166
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Nasal polyp,22772,95,0.98 [0.84-1.13],0.7348959113441371
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23047,370,0.98 [0.91-1.05],0.5267082504124329
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22873,196,0.93 [0.83-1.03],0.1685349554259814
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13779,43,1.09 [0.92-1.30],0.311167066649026
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21973,773,1.01 [0.96-1.06],0.6526331012828677
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Early onset COPD,23400,92,1.01 [0.82-1.25],0.8946400139538336
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23400,92,1.01 [0.82-1.25],0.8946400139538336
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",23400,92,1.01 [0.82-1.25],0.8946400139538336
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22489,699,1.00 [0.94-1.05],0.8531506066148106
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Asthma,18337,699,0.99 [0.94-1.05],0.7694490996811018
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18206,699,0.99 [0.94-1.05],0.7578982509048537
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18322,684,0.99 [0.94-1.05],0.8443243955493259
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23858,57,0.97 [0.76-1.23],0.7714775955687273
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22856,43,0.99 [0.76-1.29],0.9454924667199984
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23915,43,0.99 [0.76-1.29],0.9374935680371058
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22850,37,1.01 [0.77-1.32],0.9607421731575434
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pleural effusion,22848,68,0.95 [0.78-1.15],0.5900911465480103
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other diseases of pleura,22935,155,0.98 [0.87-1.11],0.7458202925777825
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23286,70,1.00 [0.84-1.18],0.9578457731203224
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,17079,4491,0.98 [0.96-1.01],0.1638839341700045
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23503,426,1.05 [0.99-1.11],0.1086971641525041
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23964,116,1.06 [0.97-1.16],0.2101911537601908
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Impacted teeth,23969,106,1.06 [0.96-1.16],0.2358259099453677
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Dental caries,23178,101,1.07 [0.95-1.19],0.2615788220722831
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23175,98,1.09 [0.98-1.23],0.1247784520798028
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23951,131,1.05 [0.97-1.14],0.2466428276227765
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23156,79,0.91 [0.76-1.10],0.3482499747994062
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22941,55,0.78 [0.56-1.08],0.1281360360568878
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23920,41,0.74 [0.49-1.10],0.1326825630215117
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19311,184,1.03 [0.93-1.15],0.5838340551883887
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20664,1537,0.99 [0.95-1.03],0.5409003798619998
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oesophagitis,19361,234,0.96 [0.87-1.07],0.4824267676979357
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19621,494,0.99 [0.92-1.06],0.7372658722492403
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19187,60,1.04 [0.88-1.23],0.6419045538740048
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19253,126,0.97 [0.85-1.12],0.7104541628858745
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19153,26,1.01 [0.75-1.35],0.9675684548384288
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastric ulcer,19219,92,1.09 [0.96-1.25],0.1876256246372273
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Duodenal ulcer,19220,93,0.91 [0.75-1.12],0.3807345824946782
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23937,66,0.95 [0.76-1.18],0.6378077921504341
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Chronic gastritis,19223,96,0.62 [0.44-0.87],0.0050877970168116
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19690,563,1.01 [0.95-1.07],0.7890796139038683
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of appendix,23867,139,0.95 [0.84-1.07],0.3832723603546584
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Functional dyspepsia,19462,335,1.01 [0.93-1.09],0.8076440886240314
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19226,99,0.98 [0.84-1.14],0.7821155496756971
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23856,168,0.97 [0.87-1.08],0.5683545936181278
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute appendicitis,23839,111,0.98 [0.87-1.10],0.69998025290173
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Hernia,21660,1043,0.93 [0.88-0.98],0.011091176302146
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Inguinal hernia,20963,346,0.86 [0.77-0.95],0.0047464676743885
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Umbilical hernia,20718,101,1.05 [0.92-1.20],0.4655414592015623
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ventral hernia,20698,81,0.86 [0.69-1.08],0.1888166762794025
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,21157,540,0.96 [0.89-1.04],0.2850719658416656
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23268,654,0.98 [0.92-1.03],0.428778838643514
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of intestines,19780,1461,0.98 [0.94-1.02],0.3109604963626398
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23738,63,0.88 [0.72-1.09],0.2453799132023222
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23953,89,0.91 [0.76-1.08],0.2612169742028165
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Crohn disease,22703,89,0.91 [0.76-1.08],0.2607478883488996
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22683,69,0.88 [0.72-1.08],0.2318062428757624
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23906,113,0.95 [0.82-1.10],0.4653996659890362
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22727,113,0.95 [0.82-1.10],0.4623505779762635
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22710,96,0.97 [0.83-1.13],0.6876091713384358
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23141,527,0.98 [0.92-1.05],0.5733928015208425
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23137,523,0.98 [0.92-1.05],0.5767592052106644
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18378,59,0.99 [0.80-1.21],0.8923365299465732
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Intestinal stricture,23725,59,0.99 [0.80-1.21],0.9092854435867184
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18360,41,1.04 [0.84-1.28],0.7444956219167609
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18591,272,0.90 [0.78-1.03],0.1160272255819561
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18468,149,1.00 [0.90-1.12],0.9781188627682932
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18537,218,0.99 [0.90-1.09],0.8441535347159093
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Constipation,23018,193,1.01 [0.92-1.11],0.818689391810218
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23644,72,1.03 [0.88-1.20],0.7302073036535275
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18476,157,0.97 [0.87-1.08],0.6066693869437434
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18400,81,0.91 [0.75-1.11],0.3568752824251607
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19014,695,0.99 [0.94-1.05],0.8316895628403801
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of intestine,18477,158,0.94 [0.81-1.09],0.4027232563658762
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23633,61,1.03 [0.88-1.22],0.6995824225773362
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of liver,23384,105,0.97 [0.83-1.14],0.7132325417274011
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of liver,23339,60,0.89 [0.69-1.15],0.3824771695236977
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22920,451,1.07 [1.00-1.13],0.0392334819075804
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Cholelithiasis,22829,360,1.03 [0.96-1.11],0.4226668221922909
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Cholecystitis,22536,67,1.06 [0.91-1.24],0.4420516283022789
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22506,37,1.21 [1.06-1.39],0.0044587741757605
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute pancreatitis,22518,49,0.80 [0.56-1.14],0.2209189751036029
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23869,49,0.80 [0.56-1.14],0.2141530120858236
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22937,246,1.02 [0.93-1.11],0.6740804270576389
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22748,57,1.08 [0.92-1.27],0.3540960574565119
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Coeliac disease,22738,47,1.09 [0.92-1.30],0.3220056823989632
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22729,38,0.88 [0.65-1.19],0.3986321816895164
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22846,155,1.02 [0.92-1.14],0.6733772266358683
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,GI-bleeding,22841,150,1.02 [0.92-1.14],0.6849110010401446
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21791,1288,0.97 [0.93-1.01],0.1564748755521429
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23694,91,1.07 [0.94-1.21],0.2948788556798088
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23662,403,0.98 [0.92-1.06],0.658504247383989
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23060,453,0.98 [0.91-1.05],0.5786346882316428
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23338,355,0.93 [0.85-1.01],0.0823746534072781
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23076,93,0.95 [0.81-1.10],0.4982187117676054
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23185,202,0.91 [0.80-1.03],0.1322652846032595
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23802,72,1.03 [0.87-1.21],0.7356727055017259
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23790,60,1.07 [0.91-1.26],0.4251905740708629
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23774,44,1.09 [0.91-1.30],0.3707816351036084
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23887,26,0.89 [0.61-1.29],0.5441331254330071
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23884,23,0.93 [0.66-1.31],0.6662320024523636
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23316,57,0.94 [0.77-1.14],0.5166555654883811
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23564,305,1.00 [0.92-1.08],0.9098259359813144
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22668,61,1.03 [0.84-1.26],0.7796129398207956
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22692,85,0.90 [0.75-1.08],0.2599692759843417
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22680,73,0.86 [0.69-1.08],0.1901230291767643
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22782,175,1.00 [0.90-1.11],0.974944295848305
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22761,154,0.94 [0.82-1.07],0.3459927012196936
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18586,3052,0.96 [0.93-0.99],0.0083140936001986
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,19974,1632,0.97 [0.93-1.01],0.0881899100318904
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21889,950,0.96 [0.92-1.02],0.1706696115806341
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18454,112,1.08 [0.96-1.22],0.219879015943711
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18648,306,1.01 [0.92-1.10],0.8644467901343238
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23729,107,1.07 [0.95-1.22],0.2746997648005278
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23741,95,1.06 [0.92-1.22],0.4213699665417031
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18915,573,0.91 [0.84-1.00],0.0405984569667574
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",21165,573,0.91 [0.84-1.00],0.0440398324074679
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18381,39,0.99 [0.74-1.32],0.9478103868307416
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23693,38,1.00 [0.75-1.33],0.9933130800542213
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18474,132,0.91 [0.76-1.08],0.2868661508769362
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18364,22,0.97 [0.59-1.58],0.891553640337509
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18451,109,0.83 [0.66-1.06],0.1378456628085885
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23923,54,0.81 [0.56-1.18],0.2722389391708746
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18631,289,0.93 [0.83-1.04],0.2012327008561271
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18533,191,0.92 [0.79-1.08],0.301122519569587
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19423,1081,0.96 [0.91-1.00],0.0729396491350386
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18380,38,0.97 [0.74-1.26],0.8007015109183307
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18496,154,1.10 [0.98-1.22],0.103493499906778
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18367,25,1.09 [0.82-1.45],0.5488683583075435
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18368,26,1.19 [0.90-1.57],0.2244810917954169
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18787,445,0.87 [0.79-0.95],0.0015879417025763
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18713,371,0.86 [0.78-0.95],0.0026374560873472
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18959,246,1.02 [0.94-1.11],0.6703349955266873
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23668,142,1.02 [0.92-1.14],0.6740314597236946
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23563,37,0.98 [0.77-1.25],0.8597135697087348
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21439,45,0.98 [0.77-1.25],0.8929284357087113
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21589,195,0.97 [0.86-1.10],0.6487248319409391
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22192,798,0.97 [0.92-1.02],0.2281051701021159
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21515,121,1.01 [0.86-1.18],0.944138872445579
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21443,49,0.90 [0.70-1.17],0.4409182892509903
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22066,672,0.97 [0.92-1.03],0.3192506438653629
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21443,49,0.98 [0.78-1.22],0.8385352897962725
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21626,232,0.88 [0.78-0.99],0.032682525333483
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21497,103,0.87 [0.74-1.03],0.1071582683500302
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21452,58,0.97 [0.79-1.19],0.7749843373411618
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21517,123,1.08 [0.97-1.21],0.1784396617264679
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21453,59,0.89 [0.72-1.11],0.3172657745331384
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21680,286,0.99 [0.91-1.08],0.8768222971899631
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21180,241,0.96 [0.86-1.06],0.3802055483971435
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20988,49,0.88 [0.66-1.18],0.3923629068944223
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20980,41,0.96 [0.75-1.24],0.7699778660591312
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,21039,100,1.01 [0.88-1.16],0.9141724765838384
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20991,52,0.99 [0.82-1.21],0.9577729278429574
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20992,53,0.84 [0.61-1.16],0.2894306107340731
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20978,39,0.76 [0.48-1.21],0.249532778955187
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21125,186,0.98 [0.86-1.11],0.6956484123634197
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20986,47,0.98 [0.78-1.23],0.8337546694678855
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20982,43,1.10 [0.87-1.40],0.4261279948134242
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21031,92,0.97 [0.81-1.16],0.7030119098961247
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,21002,63,1.01 [0.85-1.20],0.8964168749714376
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21322,383,0.99 [0.92-1.07],0.7651668419205943
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21072,133,0.99 [0.87-1.13],0.8900527862188119
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21136,197,0.99 [0.90-1.10],0.8883778789331112
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22804,91,0.96 [0.79-1.16],0.6804452915214736
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23005,292,0.97 [0.89-1.06],0.5013865797388978
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22761,48,0.76 [0.55-1.06],0.1047463268900851
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22769,56,1.04 [0.87-1.24],0.6639608947828082
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22813,100,1.03 [0.90-1.18],0.6962804741264719
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20349,3787,1.05 [1.03-1.08],1.5049993228575582e-05
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,9750,346,1.06 [0.86-1.31],0.56251611369292
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22720,164,1.07 [0.97-1.17],0.1969509585940517
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22603,47,1.04 [0.85-1.27],0.6937182479110937
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22859,32,0.93 [0.68-1.26],0.6361997382770033
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22859,32,1.24 [1.05-1.46],0.0128643361453032
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22867,40,1.05 [0.88-1.26],0.5841987922626848
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23706,200,0.96 [0.86-1.06],0.4310226491303895
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23769,48,0.96 [0.75-1.22],0.7226736051281963
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23646,140,0.98 [0.87-1.10],0.6901201972848425
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23588,82,1.01 [0.87-1.16],0.9359695281886904
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22716,766,1.03 [0.98-1.08],0.3149715354479218
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Cystitis,22021,71,0.93 [0.75-1.15],0.4940966808411596
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,22007,57,1.08 [0.90-1.30],0.400344252927058
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22104,154,0.86 [0.72-1.03],0.1017558976011685
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,22030,80,0.97 [0.82-1.16],0.7701029686241649
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22489,539,1.06 [1.00-1.12],0.0372224885544653
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9463,59,1.57 [1.06-2.33],0.0229084829201292
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9437,33,0.94 [0.48-1.84],0.8679494986224576
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Hydrocele,9439,35,0.97 [0.51-1.86],0.9269708465662224
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9475,71,1.03 [0.66-1.62],0.8912435539860986
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9460,56,1.08 [0.65-1.78],0.7706806715607504
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9486,82,1.15 [0.76-1.73],0.5091293718408412
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13129,218,0.99 [0.92-1.07],0.823218488496162
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12977,66,0.97 [0.84-1.12],0.7164949477696473
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,12984,73,0.99 [0.87-1.13],0.8942412819519377
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12958,47,1.09 [0.95-1.25],0.239525864050619
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,13096,339,0.96 [0.90-1.01],0.1367371683595017
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,12828,71,0.90 [0.77-1.04],0.1609573353226909
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12926,169,0.93 [0.86-1.01],0.1062792869971246
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12083,2387,0.95 [0.93-0.98],0.0002363148279389
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9942,246,0.86 [0.79-0.93],0.0003285706761818
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,9772,76,0.82 [0.71-0.95],0.0090818662276161
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9794,98,0.90 [0.79-1.03],0.1160884523516527
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9960,264,0.99 [0.91-1.07],0.7461806170790936
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9962,266,0.90 [0.83-0.97],0.0056079062186807
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10114,418,0.93 [0.87-1.00],0.04247379388999
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9844,148,0.94 [0.83-1.05],0.282528414149955
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9885,189,0.97 [0.89-1.06],0.5243622420141153
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9769,73,0.91 [0.80-1.05],0.2117837315804485
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9825,129,1.01 [0.93-1.09],0.8434764351179163
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",13257,175,1.03 [0.96-1.10],0.4620918281372126
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,13266,168,1.03 [0.96-1.10],0.4641289696748804
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,13282,94,1.01 [0.92-1.11],0.8157919829696232
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",13274,102,1.01 [0.92-1.11],0.810260183090592
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9756,60,0.91 [0.76-1.08],0.288106320153859
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9750,54,0.85 [0.70-1.03],0.1014148204186957
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9758,62,1.00 [0.89-1.13],0.952584019506638
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Irregular menses,13196,319,0.97 [0.91-1.04],0.367451582764988
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10681,985,0.95 [0.92-0.99],0.013860199394035
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,10376,680,0.94 [0.90-0.98],0.0084233750828215
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",13269,138,0.91 [0.81-1.02],0.116785028232256
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,10000,304,0.95 [0.89-1.01],0.1263370423423461
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9925,229,0.93 [0.87-1.00],0.0459024799987936
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9918,222,0.87 [0.73-1.03],0.1149493403199103
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Female infertility,9779,83,0.96 [0.87-1.05],0.3355368983919027
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",9772,76,0.98 [0.90-1.07],0.648523982859718
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,13274,718,1.02 [0.99-1.05],0.1512943409729181
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,13281,985,1.04 [1.01-1.06],0.0116026278958427
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,13275,378,1.04 [1.00-1.08],0.041250340470306
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,13004,107,0.99 [0.92-1.07],0.8891668738299873
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,13043,146,1.06 [0.99-1.12],0.0743104092050563
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,13034,137,1.05 [0.99-1.12],0.1323176863601524
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",13291,142,0.95 [0.89-1.02],0.1734153338675672
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,13293,139,0.95 [0.88-1.02],0.1428714231999036
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,13291,351,1.01 [0.97-1.05],0.6658270591588018
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,13043,103,0.93 [0.85-1.01],0.0963451059496393
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,13136,196,1.05 [1.00-1.11],0.059976750249395
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,12679,123,1.00 [0.94-1.07],0.8951843005965432
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,12721,165,0.99 [0.93-1.06],0.8339317022174619
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,12756,200,1.03 [0.97-1.08],0.337006891259485
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,12677,121,0.97 [0.90-1.04],0.3662297022522437
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,12668,112,1.00 [0.93-1.07],0.975804606786424
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,12682,126,1.02 [0.95-1.09],0.6112987447965657
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,12480,184,1.02 [0.97-1.08],0.4509125329868466
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],12660,364,1.03 [0.99-1.07],0.1651264380840518
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,12844,548,1.04 [1.01-1.07],0.0239483354734177
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",13296,144,1.05 [1.00-1.12],0.0698532705269115
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,12102,110,1.07 [1.00-1.14],0.0476508152356193
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",12379,83,1.04 [0.97-1.13],0.2679821194056943
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,13301,279,1.05 [1.01-1.10],0.0210591052236421
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,13238,216,1.07 [1.02-1.12],0.0082128296441472
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",13290,214,1.01 [0.96-1.07],0.6275130695123926
RLN2,Prorelaxin H2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",13280,204,1.01 [0.96-1.07],0.6190069732370356
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23808,31,1.00 [0.76-1.32],0.9950805130626208
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22588,439,0.93 [0.86-1.01],0.0702276543494776
